ConductScience.org, home

Paper11040176

A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease.

Markowitz J and 4 others. Gastroenterology, 2000. Cited by 562 papers, by iCite.

Cite this record

ConductScience Library. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Papers, record 11040176. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11040176

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease.
PubMed
Journal
Gastroenterology
PubMed
Year
2000
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
562
iCite
Relative citation ratio, by iCite
16.7
iCite
Revised in PubMed
2022-04-09
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Markowitz JJ
2Grancher KK
3Kohn NN
4Lesser MM
5Daum FF

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Crohn DiseaseMajor topic
Immunosuppressive AgentsMajor topic
MercaptopurineMajor topic
PrednisoneMajor topic
Adolescent
Child
Disease-Free Survival
Double-Blind Method
Drug Therapy, Combination
Female
Glucocorticoids
Growth
Humans
Male
Prospective Studies

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02852694Reduce Risk for Crohn's Disease PatientsBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in110402026-Mercaptopurine in maintaining remission in Crohn's disease: An old friend becomes a new hero.https://conductscience.org/library/papers/11040202PubMed
Comment in113535606-Mercaptopurine for children newly diagnosed with Crohn's disease.https://conductscience.org/library/papers/11353560PubMed

Download CSV of comments and corrections

Cited by159

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 562 citations.

PMIDTitleJournalYearIn PapersSource
42099516Enteral nutrition versus immunomodulators for induction and maintenance of remission in pediatric Crohn's disease: a systematic review and network meta-analysis.Front Pediatr2026https://conductscience.org/library/papers/42099516PubMed
41532979Combining thiopurine with partial enteral nutrition promotes complete mucosal healing in pediatric Crohn's disease.Pediatr Int2026https://conductscience.org/library/papers/41532979PubMed
41323518Evolution of Growth following Anti-Tumor Necrosis Factor-α Therapy in Paediatric Crohn's Disease: Data from the Swiss IBD Cohort Study.Inflamm Intest Dis2025https://conductscience.org/library/papers/41323518PubMed
41300822Pharmacogenetic Analysis of TPMT and NUDT15 in a European Pediatric Cohort with IBD and Autoimmune Diseases: Frequency Data and Clinical Relevance.Genes (Basel)2025https://conductscience.org/library/papers/41300822PubMed
41274746AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease.Gastroenterology2025https://conductscience.org/library/papers/41274746PubMed
39200937Common Mistakes in Managing Patients with Inflammatory Bowel Disease.J Clin Med2024https://conductscience.org/library/papers/39200937PubMed
38788739Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients.Inflamm Bowel Dis2024https://conductscience.org/library/papers/38788739PubMed
37967391Diagnostic Considerations in Pediatric Inflammatory Bowel Disease Management.Gastroenterol Hepatol (N Y)2009https://conductscience.org/library/papers/37967391PubMed
37787346Efficacy of early biologic therapy versus late/conventional therapy in children and adolescents with Crohn's disease: A systematic review and meta-analysis.Saudi J Gastroenterol2023https://conductscience.org/library/papers/37787346PubMed
37695555Precision Dosing of Anti-TNF Therapy in Pediatric Inflammatory Bowel Disease.Curr Gastroenterol Rep2023https://conductscience.org/library/papers/37695555PubMed
37338669Inflammatory Bowel Disease in Children.Indian J Pediatr2024https://conductscience.org/library/papers/37338669PubMed
37240524Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease.J Clin Med2023https://conductscience.org/library/papers/37240524PubMed
37215203Efficacy of short-chain polypeptide-based EEN formulas in alleviating intestinal injury in children with Crohn's disease: a single-center study in China.Front Nutr2023https://conductscience.org/library/papers/37215203PubMed
36798512Thiopurine Methyltransferase Activity and Thiopurine Metabolites in Inflammatory Bowel Disease.Crohns Colitis 3602020https://conductscience.org/library/papers/36798512PubMed
36123761Digital Therapeutic Self-Management Intervention in Adolescents With Inflammatory Bowel Disease.J Pediatr Gastroenterol Nutr2023https://conductscience.org/library/papers/36123761PubMed
36008595Prediction of thiopurine failure in pediatric Crohn's disease: pediatric IBD Porto group of ESPGHAN.Pediatr Res2023https://conductscience.org/library/papers/36008595PubMed
35687221Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease.Dig Dis Sci2023https://conductscience.org/library/papers/35687221PubMed
35401955Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn's disease: a systematic review.Frontline Gastroenterol2021https://conductscience.org/library/papers/35401955PubMed
35368318Recommendation Reversals in Gastroenterology Clinical Practice Guidelines.J Can Assoc Gastroenterol2022https://conductscience.org/library/papers/35368318PubMed
33532972Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study.Dig Dis Sci2022https://conductscience.org/library/papers/33532972PubMed

See all 159 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11040176

GET https://conductscience.org/api/papers/v1/11040176/cited_by?page=2